Medical device cybersecurity is crucial for patient safety and regulatory compliance. Robust cybersecurity measures are essential to navigate the complex landscape of FDA requirements and protect against evolving threats.
A single vulnerability can hit all three rows at once — which is why cybersecurity earns its own lifecycle program.
Utilize refined, medical technology-specific penetration testing and security protocols rather than generic IT checklists to ensure comprehensive protection for your devices.
Routinely test specialized medical protocols such as DICOM, HL7/FHIR, MedRadio, and BLE Medical to identify and mitigate vulnerabilities unique to their attack surfaces.
Perform penetration testing not only on the medical device itself but also on its entire ecosystem, including cloud backend and mobile companion applications, for complete security assurance.
Thoroughly test wireless, Bluetooth, and radio frequency communication for connected devices, as these are critical attack vectors often overlooked or minimally scoped.
Go beyond standard IT penetration testing by employing bus sniffing, JTAG/UART analysis, firmware extraction, and protocol fuzzing to uncover deeper, hardware-level vulnerabilities.
Align cybersecurity risk assessments with ISO 14971 to directly link cyber risks to potential patient harm, ensuring that security measures protect both data and human well-being.
Consistently conduct threat modeling using methodologies like STRIDE and attack trees to proactively identify potential threats and vulnerabilities throughout the device lifecycle.
Develop and maintain accurate SBOMs to understand software components, track their vulnerabilities, and manage risks effectively.
Integrate SAST into the development pipeline to automatically identify security vulnerabilities in source code before deployment.
Establish continuous monitoring systems to track and respond to new vulnerabilities that emerge after a device has been deployed, ensuring ongoing security.
Authoritative guidance and standards underpinning this topic. Always confirm the latest revision with the publisher.
Quick answers to the questions teams most often ask about this topic.
Insecure devices can directly harm patients (e.g., manipulated dosing or disabled therapy), expose protected health information, and trigger product recalls. They also create regulatory, brand, and revenue risk: the FDA can refuse to clear a device, and hospitals increasingly require security attestations before purchase.
Consequences range from patient safety incidents and PHI breaches to mandatory recalls, FDA enforcement, lawsuits, and loss of hospital contracts. Even a vulnerability without active exploitation can require coordinated disclosure, patch development, and customer notification.
Increasingly, yes. Hospital procurement teams use the MDS2 form and require evidence of secure development. Devices with strong, documented security posture clear procurement faster and command pricing power.